Tyrosine Kinase Inhibitor Pazopanib Inhibits Platelet Procoagulant Activity in Renal Cell Carcinoma Patients

Pazopanib is an angiostatic tyrosine kinase inhibitor (TKI) presently used for cancer treatment, particularly in patients with renal cell carcinoma (RCC). This treatment can be accompanied by mild bleeding as an adverse effect. Given the role of protein tyrosine kinases in platelet activation proces...

全面介紹

Na minha lista:
書目詳細資料
發表在:Front Cardiovasc Med
Main Authors: Tullemans, Bibian M. E., Nagy, Magdolna, Sabrkhany, Siamack, Griffioen, Arjan W., oude Egbrink, Mirjam G. A., Aarts, Maureen, Heemskerk, Johan W. M., Kuijpers, Marijke J. E.
格式: Artigo
語言:Inglês
出版: Frontiers Media S.A. 2018
主題:
Cardiovascular Medicine
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC6232667/
https://ncbi.nlm.nih.gov/pubmed/30460241
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fcvm.2018.00142
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍